Concepedia

Masaya Shimanuki

MS

6

Publications

303

Citations

6

H-Index

2008

Active since

Affiliations

Wakayama Medical University(Current)

Kumamoto University

The University of Texas MD Anderson Cancer Center

Aichi Medical University

Masaya Shimanuki is an author at Wakayama Medical University specializing in medicine, tumor biology, and cancer research.

Top concepts

MedicineCell BiologyTumor BiologyCancer ResearchApoptosisCell DeathRadiation OncologyMitochondrial FunctionAllergyOncology

Publications per year

2008–2020

6

Publications

6

The dual PI3 kinase/mTOR inhibitor PI-103 prevents p53 induction by Mdm2 inhibition but enhances p53-mediated mitochondrial apoptosis in p53 wild-type AML

Kensuke Kojima, Masaya Shimanuki, Masato Shikami et al. · Leukemia · 2008 · 115 citations

Mitochondrial Function, Medicine, P53 Wild-type Aml +10

Eμ/miR-125b transgenic mice develop lethal B-cell malignancies

Yutaka Enomoto, Jiro Kitaura, Kinta Hatakeyama et al. · Leukemia · 2011 · 81 citations · Full text

Tumor Biology, Medicine, Eμ/mir-125b Transgenic Mice +5

Cyclin‐dependent kinase 1 inhibitor RO‐3306 enhances p53‐mediated Bax activation and mitochondrial apoptosis in AML

Kensuke Kojima, Masaya Shimanuki, Masato Shikami et al. · Cancer Science · 2009 · 49 citations · Full text

Chemoprevention Strategy, Apoptosis, Cell Death +17

NKG2D‐mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes

Nobuyoshi Hanaoka, Hideki Nakakuma, Kentaro Horikawa et al. · British Journal of Haematology · 2009 · 29 citations · Full text

Clinical Immunology, Immunology, Blood Cell +19

Acute Leukemia Showing t(8;22)(p11;q11), Myelodysplasia, CD13/CD33/CD19 Expression and Immunoglobulin Heavy Chain Gene Rearrangement

Masaya Shimanuki, Takashi Sonoki, Hiroki Hosoi et al. · Acta Haematologica · 2013 · 16 citations

Rows per page

1–5 of 6